Alpha-synuclein misfolding as fluid biomarker for Parkinson’s disease measured with the iRS platform

Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years

TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis